Positive outcome in a patient with Wilson's disease treated with reduced zinc dosage in pregnancy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 159, Issue 1, 2011, Pages 237-238

  Masciullo, Marcella ^a,b   Modoni, Anna ^a   Bianchi, Maria Laura Ester ^a,c   De Carolis, Sara ^a   Silvestri, Gabriella ^a,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; ZINC; ZINC ACETATE;

ADULT; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; COPPER BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MONITORING; DYSARTHRIA; FEMALE; FETUS DEVELOPMENT; HUMAN; LETTER; LIVER LEVEL; LOW DRUG DOSE; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREMOR; URINE LEVEL; WILSON DISEASE; ZINC BLOOD LEVEL;

EID: 81855176217     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.06.040     Document Type: Letter

References (5)

1. A. Ala, A.P. Walker, K. Ashkan, J.S. Dooley, and M.L. Schilsky Wilson's disease Lancet 369 2007 397 408
2. E.A. Roberts, M.L. Schilsky American Association for Study of Liver Diseases (AASLD) Diagnosis and treatment of Wilson disease: an update Hepatology 47 2008 2089 2111
3. T.U. Hoogenraad, R. Koevoet, and E.G. de Ruyter Korver Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration) Eur Neurol 18 1979 205 211
4. M. Marcellini, V. Di Ciommo, and F. Callea Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study J Lab Clin Med 145 2005 139 143
5. G.J. Brewer, V.D. Johnson, R.D. Dick, P. Hedera, J.K. Fink, and K.J. Kluin Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy Hepatology 31 2000 364 370